Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Neveu

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Cancer Research|March 15, 1988
Expression of the c-raf protooncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasmsD G Beer, M J Neveu, D L Paul, et al.
Brain Research Bulletin|December 31, 2003
Chronic psychosocial stress down-regulates central cytokines mRNAAlessandro Bartolomucci, Paola Palanza, Stefano Parmigiani, et al.
Psychoneuroendocrinology|October 5, 2001
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapyL Capuron, A Ravaud, N Gualde, et al.
Brain Research|September 25, 1989
Functional brain asymmetry and murine systemic lupus erythematosusP J Neveu, C Betancur, P Barnéoud, et al.
Neuroscience|January 1, 1995
Paw preference and brain dopamine asymmetriesS Cabib, F R D'Amato, P J Neveu, et al.
Neuroscience|February 8, 2003
Brain interleukin asymmetries and paw preference in miceQ L Fu, Y Q Shen, M X Gao, et al.
Brain Research|May 21, 1990
The nucleus basalis is involved in brain modulation of the immune system in ratsJ Cherkaoui, W Mayo, P J Neveu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 20, 2000
Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapyM Maes, L Capuron, A Ravaud, et al.
Annals of Neurology|June 3, 2004
Role of cerebral lateralization in control of immune processes in humansKimford J Meador, David W Loring, Patty G Ray, et al.
Cancer Research|June 15, 1994
Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promotersM J Neveu, K L Babcock, E L Hertzberg, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Cancer Research|March 15, 1988
Expression of the c-raf protooncogene, gamma-glutamyltranspeptidase, and gap junction protein in rat liver neoplasmsD G Beer, M J Neveu, D L Paul, et al.
Brain Research Bulletin|December 31, 2003
Chronic psychosocial stress down-regulates central cytokines mRNAAlessandro Bartolomucci, Paola Palanza, Stefano Parmigiani, et al.
Psychoneuroendocrinology|October 5, 2001
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapyL Capuron, A Ravaud, N Gualde, et al.
Brain Research|September 25, 1989
Functional brain asymmetry and murine systemic lupus erythematosusP J Neveu, C Betancur, P Barnéoud, et al.
Neuroscience|January 1, 1995
Paw preference and brain dopamine asymmetriesS Cabib, F R D'Amato, P J Neveu, et al.
Neuroscience|February 8, 2003
Brain interleukin asymmetries and paw preference in miceQ L Fu, Y Q Shen, M X Gao, et al.
Brain Research|May 21, 1990
The nucleus basalis is involved in brain modulation of the immune system in ratsJ Cherkaoui, W Mayo, P J Neveu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 20, 2000
Lowered serum dipeptidyl peptidase IV activity is associated with depressive symptoms and cytokine production in cancer patients receiving interleukin-2-based immunotherapyM Maes, L Capuron, A Ravaud, et al.
Annals of Neurology|June 3, 2004
Role of cerebral lateralization in control of immune processes in humansKimford J Meador, David W Loring, Patty G Ray, et al.
Cancer Research|June 15, 1994
Colocalized alterations in connexin32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promotersM J Neveu, K L Babcock, E L Hertzberg, et al.
Pageof 14